Location: Hellerup, Denmark
CIK: 0001388325 · Show all filings
Period: Q1 2014 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value: $853M
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| VTI | VANGUARD INDEX FDS | 2,979,100 | $290M | 34.1% | $97.47 | $57.39 | — | TOTAL STK MKT | 922908769 |
| — | OPHTHOTECH CORP | 6,910,489 | $246M | 28.9% | $35.67 | $32.35 | — | COM | 683745103 |
| VGK | VANGUARD INTL EQUITY INDEX F | 2,101,000 | $126M | 14.8% | $59.90 | $45.01 | — | FTSE EUROPE ETF | 922042874 |
| INGN | INOGEN INC | 5,419,449 | $89.47M | 10.5% | $16.51 * | $17.78 | 0.0% | COM | 45780L104 |
| — | FLEXION THERAPEUTICS INC ⚠ | 1,783,131 | $29.33M | 3.4% | $16.45 | $16.45 | — | — | 33938J106 |
| — | FLEXION THERAPEUTICS ⚠ | 1,783,131 | $29.33M | 3.4% | $16.45 | $16.45 | — | COM | 33938J106 |
| — | WRIGHT MED GROUP INC | 585,759 | $18.2M | 2.1% | $31.07 | $23.81 | — | COM | 98235T107 |
| — | TETRAPHASE PHARMACEUTICALS INC | 900,000 | $9.801M | 1.1% | $10.89 | $13.52 | — | COM | 88164N105 |
| — | TETRAPHASE PHARMACEUTICALS INC | 900,000 | $9.801M | 1.1% | $10.89 | $13.52 | — | COM | 88165N105 |
| — | WRIGHT MED GROUP INC | 4,720,065 | $3.918M | 0.5% | $0.83 | $2.50 | — | RIGHT 03/01/2019 | 98235T115 |